# 908 Devices Inc.: overview MASS · Nasdaq · CIK 1555279 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/mass.md) · [Financials](/companies/mass/financials.md) · [Filings](/companies/mass/filings.md) · [Insiders](/companies/mass/insiders.md) Latest reported revenue: [$16.1m](/filings/0001104659-26-093731.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 11, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001104659-26-093731). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [14.5](/filings/0001104659-25-108875.md) | [14.3 d](/filings/0001104659-26-024877.md) | [11.8](/filings/0001104659-26-055917.md) | [13.0](/filings/0001104659-26-093731.md) | [14.0](/filings/0001104659-25-108875.md) | [17.4 d](/filings/0001104659-26-024877.md) | [13.4](/filings/0001104659-26-055917.md) | [16.1](/filings/0001104659-26-093731.md) | | Gross margin | % | [53.6%](/filings/0001104659-25-108875.md) | [46.5% d](/filings/0001104659-26-024877.md) | [47.0%](/filings/0001104659-26-055917.md) | [48.9%](/filings/0001104659-26-093731.md) | [52.5%](/filings/0001104659-25-108875.md) | [52.7% d](/filings/0001104659-26-024877.md) | [51.4%](/filings/0001104659-26-055917.md) | [51.9%](/filings/0001104659-26-093731.md) | | Operating margin | % | [(168.7%)](/filings/0001104659-25-108875.md) | [(116.8%) d](/filings/0001104659-26-024877.md) | [(93.6%)](/filings/0001104659-26-055917.md) | [(116.3%)](/filings/0001104659-26-093731.md) | [(116.6%)](/filings/0001104659-25-108875.md) | [17.8% d](/filings/0001104659-26-024877.md) | [(96.3%)](/filings/0001104659-26-055917.md) | [(79.7%)](/filings/0001104659-26-093731.md) | | Net margin | % | [(201.8%)](/filings/0001104659-25-108875.md) | [(135.6%) d](/filings/0001104659-26-024877.md) | [370.2%](/filings/0001104659-26-093731.md) | [(102.1%)](/filings/0001104659-26-093731.md) | [(107.0%)](/filings/0001104659-25-108875.md) | [24.0% d](/filings/0001104659-26-024877.md) | [(89.3%)](/filings/0001104659-26-093731.md) | [(74.0%)](/filings/0001104659-26-093731.md) | | Diluted EPS | $ per share | [(0.84)](/filings/0001104659-25-108875.md) | not reported | [1.23](/filings/0001104659-26-055917.md) | [(0.37)](/filings/0001104659-26-093731.md) | [(0.41)](/filings/0001104659-25-108875.md) | not reported | [(0.32)](/filings/0001104659-26-055917.md) | [(0.32)](/filings/0001104659-26-093731.md) | | Free cash flow | $m | [(5.8) d](/filings/0001104659-25-108875.md) | [(2.4) d](/filings/0001104659-26-024877.md) | [(15.2)](/filings/0001104659-26-055917.md) | [(5.9) d](/filings/0001104659-26-093731.md) | [(4.9) d](/filings/0001104659-25-108875.md) | [1.3 d](/filings/0001104659-26-024877.md) | [1.2](/filings/0001104659-26-055917.md) | [3.0 d](/filings/0001104659-26-093731.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [42.2](/filings/0001558370-23-003887.md) | [46.9](/filings/0001558370-24-002818.md) | [50.2](/filings/0001558370-25-002459.md) | [47.7](/filings/0001104659-26-024877.md) | [56.2](/filings/0001104659-26-024877.md) | | Gross margin | % | [55.0%](/filings/0001558370-23-003887.md) | [55.5%](/filings/0001558370-24-002818.md) | [50.4%](/filings/0001558370-25-002459.md) | [51.3%](/filings/0001104659-26-024877.md) | [50.6%](/filings/0001104659-26-024877.md) | | Operating margin | % | [(52.3%)](/filings/0001558370-23-003887.md) | [(75.5%)](/filings/0001558370-24-002818.md) | [(85.1%)](/filings/0001558370-25-002459.md) | [(120.2%)](/filings/0001104659-26-024877.md) | [(70.1%)](/filings/0001104659-26-024877.md) | | Net margin | % | [(52.5%)](/filings/0001558370-23-003887.md) | [(71.6%)](/filings/0001558370-24-002818.md) | [(72.5%)](/filings/0001558370-25-002459.md) | [(151.2%)](/filings/0001104659-26-024877.md) | [34.7%](/filings/0001104659-26-024877.md) | | Diluted EPS | $ per share | [(0.79)](/filings/0001558370-23-003887.md) | [(1.07)](/filings/0001558370-24-002818.md) | [(1.13)](/filings/0001558370-25-002459.md) | [(2.12)](/filings/0001104659-26-024877.md) | [0.54](/filings/0001104659-26-024877.md) | | Free cash flow | $m | [(29.8)](/filings/0001558370-23-003887.md) | [(23.0)](/filings/0001558370-24-002818.md) | [(27.1)](/filings/0001558370-25-002459.md) | [(30.8)](/filings/0001104659-26-024877.md) | [(24.6)](/filings/0001104659-26-024877.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/mass/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [First Light Asset Management, LLC](/funds/1600004.md) | 2026-06-30 | $54.7m | 6,282,804 | | Added +210,241 | | [AWM Investment Company, Inc.](/funds/1535264.md) | 2026-06-30 | $42.5m | 4,879,773 | | Reduced −320,151 | | [ARK Investment Management LLC](/funds/1697748.md) | 2026-06-30 | $17.6m | 2,027,920 | | Added +81,235 | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $16.9m | 1,944,236 | | Added +176,920 | | [NEEDHAM INVESTMENT MANAGEMENT LLC](/funds/1167212.md) | 2026-06-30 | $15.8m | 1,820,620 | | Added +580,620 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $11.2m | 1,291,570 | | Added +172,334 | | [First Eagle Investment Management, LLC](/funds/1325447.md) | 2026-06-30 | $8.1m | 929,985 | | Added +126,379 | | [First Eagle Investment Management, LLC](/funds/1325447.md) | 2026-06-30 | $8.1m | 929,985 | | Added +126,379 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $6.6m | 761,797 | | Added +66,342 | | [Granahan Investment Management, LLC](/funds/1026710.md) | 2026-06-30 | $6.0m | 692,092 | | Reduced −2,978 | ## Recent filings [All 477 filings](/companies/mass/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-08-11 | 11:20 ET | [10-Q](/filings/0001104659-26-093731.md) | Quarterly report, period 2026-06-30 | 0001104659-26-093731 | | 2026-08-11 | 11:05 ET | [8-K](/filings/0001104659-26-093717.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-093717 | | 2026-07-08 | 20:30 ET | [8-K](/filings/0001104659-26-081806.md) | 8.01 Other events | 0001104659-26-081806 | | 2026-06-12 | 20:20 ET | [8-K](/filings/0001104659-26-073487.md) | 5.07 Shareholder vote results | 0001104659-26-073487 | | 2026-05-06 | 11:45 ET | [10-Q](/filings/0001104659-26-055917.md) | Quarterly report, period 2026-03-31 | 0001104659-26-055917 | | 2026-05-06 | 11:35 ET | [8-K](/filings/0001104659-26-055912.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.02 Results of operations; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-055912 | | 2026-04-29 | 11:05 ET | [DEF 14A](/filings/0001104659-26-050795.md) | Proxy statement, period 2026-06-11 | 0001104659-26-050795 | | 2026-03-09 | 10:12 ET | [10-K](/filings/0001104659-26-024877.md) | Annual report, period 2025-12-31 | 0001104659-26-024877 | | 2026-03-03 | 12:15 ET | [8-K](/filings/0001104659-26-022548.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-022548 | | 2026-01-20 | 12:15 ET | [8-K](/filings/0001104659-26-004798.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-004798 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001104659-26-024877.md), filed Mar 9, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/ee5042b4-d21e-4627-84bf-a31f7bf07826) ## About the filer - CIK: 1555279 - Tickers: MASS - Exchange: Nasdaq - SIC code: 3826 Laboratory Analytical Instruments - State of incorporation: DE - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:42 ET. No prices; not investment advice.